Venetoclax-IDH inhibitor combination therapy for AML

preview_player
Показать описание
Naval Daver, MD, of the University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of Venetoclax in combination with IDH inhibitors as therapy for acute myeloid leukemia (AML). This video was recorded at the International Workshop on Acute Leukemias (iwAL) 2019, held in Barcelona, Spain.
Рекомендации по теме